‘Every unborn child is a human being’: Court blocks mail distribution of deadly abortion drug
A federal court has released a ruling that blocks the mail distribution of the deadly abortion drug mifepristone.
According to a ruling from a panel at the 5th U.S. Circuit Court of Appeals in New Orleans, the state of Louisiana likely will win its challenge to the rule adopted in 2023 by Joe Biden’s administration.
Promoting abortion was one of the key agenda points of the Biden administration, another being promoting transgenderism for children.
The ruling is temporary but it’s a first step in a campaign to limit access to the drug, which has been targeted in a long list of lawsuits.
The 2023 regulation removed a requirement that mifepristone be dispensed in person, meaning that under the Biden plan, men could order the drug and give it to women who did not suspect they were being forced into abortions.
5th Circuit Panel Blocks 2023 Mifepristone Telemedicine Approval. This case will go to the Supreme Court very quickly. https://t.co/ODnnGiFvFG
— Josh Blackman (@JoshMBlackman) May 1, 2026
Another MAJOR win to report on this Friday.
— Attorney General Liz Murrill (@AGLizMurrill) May 1, 2026
BREAKING — A 5th U.S. Circuit Court of Appeals panel has blocked an FDA rule that allows women to obtain the abortion drug mifepristone by mail.
https://t.co/jzsYaDRRr3 pic.twitter.com/UpWCkwxXzs— Toria Brooke (@realtoriabrooke) May 1, 2026
Roughly two-thirds of abortions in America every year use the chemical abortion process.
Louisiana had filed a lawsuit last year against the federal government’s Food and Drug Administration.
The opinion, authored by Circuit Judge Kyle Duncan, was joined by Judges Leslie Southwick and Kurt Engelhardt.
They found that the federal rules allowed “an effective way for an out-of-state prescriber to place the drug in the hands of Lousianans in defiance of Louisiana law.”
Telehealth “appointments” for obtaining the deadly chemical were authorized during the COVID pandemic and Biden then pushed to finalize rules that opened the mail-order free-for-all.
“Every abortion facilitated by FDA’s action cancels Louisiana’s ban on medical abortions and undermines its policy that ‘every unborn child is a human being from the moment of conception and is, therefore, a legal person,'” said the decision from the appellate level court.
CNN reported that a lawyer with the pro-abortion Reproductive Freedom Project insisted the decision “defies clear science.”
The Trump administration has promised a federal review of the current regulations but has stopped short of reinstating the mail order ban.
The legal team at ADF said when the Biden administration “removed the safeguard of in-person dispensing for the abortion drug mifepristone, it intentionally opened the door for out-of-state pro-abortion activists and doctors to mail streams of high-risk abortion drugs into pro-life states.”
Joining Louisiana in the fight was Rosalie Markezich, a Louisiana woman coerced into taking abortion drugs that her boyfriend obtained via mail from a doctor in California.
“The Biden FDA’s unlawful authorization of mail-order abortion drugs was meant to nullify state laws that protect life,” said ADF Of Counsel Erin Hawley, who argued alongside Louisiana at the district court. “This was a reckless political action that destroys unborn life, puts women’s safety in serious jeopardy, and completely subverts state law. ADF applauds the court’s decision to halt this scheme and uphold the protection and dignity of every woman and child while we appeal.”
The AG said, “The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other states) through illegal mail order abortion pills.”